L3 Technologies [LLL] on Thursday said it has completed its $117.5 million acquisition of the explosive trace detection business of Implant Sciences, adding a new product to its portfolio of security detection technologies.
The trace detection business will be integrated into L3’s Security & Detection Systems division that is part of the company’s Electronic Systems business segment.
Implant’s products are used by the Transportation Security Administration, transportation security agencies in Europe, China and elsewhere, and for critical infrastructure protection.
“We are pleased to complete the acquisition of this business, which bolsters L3’s leadership in efficient, scalable security solutions and greatly enhances our capabilities in the global aviation security and national security markets,” Michael Strianese, L3’s chairman and CEO, said in a statement. “Adding Implant’s ETD business complements our market-leading checkpoint management systems and security efficiency software through our recent acquisition of MacDonald Humfrey. Together, these businesses provide L3 with a full suite of solutions and position us to capitalize on the significant opportunities in the growing security and detection market.”
L-3’s primary products in the aviation security space, in addition to its new ETD line, include body scanners, explosive detection systems (EDS) to screen checked bags, motorized tray management systems through the MacDonald deal, and a new EDS-like system that the company is introducing for screening carry-on bags at checkpoints.
Tom Ripp, president of L3 Security & Detection Systems, said in a statement that Implant’s management team is onboard and “brings both strong domain expertise couple with deep technical capabilities focused on innovative trace solutions.”
Implant’s sales in its quarter that ended Sept. 30, 2016 were $8.1 million. The company posted a net loss of $27.3 million.